Clarity Pharmaceuticals (Clarity Pharmaceuticals) Accumulated Depreciation : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Clarity Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Clarity Pharmaceuticals's quarterly accumulated depreciation increased from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($-0.15 Mil) but then stayed the same from Jun. 2023 ($-0.15 Mil) to Dec. 2023 ($0.00 Mil).

Clarity Pharmaceuticals's annual accumulated depreciation declined from . 20 ($0.00 Mil) to Jun. 2022 ($-0.09 Mil) but then increased from Jun. 2022 ($-0.09 Mil) to Jun. 2023 ($-0.15 Mil).

Clarity Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Clarity Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Accumulated Depreciation Chart

Clarity Pharmaceuticals Annual Data

Trend

Jun22

Jun23

Accumulated Depreciation

-0.09

-0.15

Clarity Pharmaceuticals Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Accumulated Depreciation	Get a 7-Day Free Trial			-	-0.09	-	-0.15	-

Clarity Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Clarity Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Clarity Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarity Pharmaceuticals (Clarity Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (OTCPK:CLRPF) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

CU6:Australia

Address

4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015

Website

https://www.claritypharmaceuticals.com

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.